• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
5285 ~hU3  A9136
5285 ~hU3 A9136

... The most important concern I have regards the efficacy of drug to be approved by this legislation. Clinical trials show that a considerable portion of drugs that have been proven to be effective based on animal research and therefore tested on Humans at least in phase I will never be approved and us ...
Use of melanotan I and II in the general population
Use of melanotan I and II in the general population

... of developing the metabolite bremelanotide (formerly known as PT-141).11 During clinical trials of bremelanotide, the drug was found to induce hypertension in some people, which led to this work being discontinued. It is now being developed as a treatment for haemorrhagic shock.11 Most users inject ...
Evolving Harm Reduction Through Peer Education
Evolving Harm Reduction Through Peer Education

... Discussing effects and sharing experiences ...
biopharmaceutical and bioproducts
biopharmaceutical and bioproducts

... BIOPRODUCTS BY PUAN AZDUWIN BINTI KHASRI 6 DECEMBER 2012 ...
Unit XIII: Treatment of Abnormal Behavior
Unit XIII: Treatment of Abnormal Behavior

... Unit XIII: Treatment of Abnormal Behavior Module 73 ...
Walgreens Health Initiatives (WHI)
Walgreens Health Initiatives (WHI)

... under this Plan subject to any applicable PPO Deductibles and Co-insurance. NOTE: Coverage, limitations, and exclusions for prescription drugs will be determined through the Prescription Drug Card program elected by the Employer and will not be subject to any limitations and exclusions under the maj ...
Psychoactive Drugs
Psychoactive Drugs

... increase the release, and decrease the removal, of norepinephrine and dopamine at synapses, resulting in increased receptor activity. Amphetamines stimulate the brain and sympathetic nervous system, raising heart rate and blood pressure and constricting blood vessels. In some extreme cases, abuse of ...
FINAL Orphan drugs – Pharma foundlings or wellsprings of wealth
FINAL Orphan drugs – Pharma foundlings or wellsprings of wealth

... Yet another strategic internal driver is the pursuit of a multiple-indication strategy. For example, in oncology, most drugs receive their highest price point when they are first reimbursed. As new indications for a particular drug are added, the price of the drug rarely, if ever, rises. In oncology ...
Introduction to Basic Pharmacology and Selected Therapies
Introduction to Basic Pharmacology and Selected Therapies

... Basic principles of drugs Administration and distribution of drugs Drugs and receptors Prescription and medication orders Other common traditional forms of therapy ...
rational drug use programme
rational drug use programme

... Misuse of antibiotics ...
UNIT 5- Drugs - fernandezappsych
UNIT 5- Drugs - fernandezappsych

... Withdrawal – discomfort and distress that follow discontinuing drug use  Physiological – physical need for a drug, without the drug one may have withdrawal symptoms (Ex. pain)  Psychological – intense desire for the drug because they are convinced they need it in order to perform or feel a certain ...
The Psychology and Physiology of Street Drugs Amie J. Hatch
The Psychology and Physiology of Street Drugs Amie J. Hatch

... • Identify new drugs of abuse • Describe the pharmacology and treatment of these drugs • Explain the impact of these drugs on trauma management ...
NEWS YOU CAN USE 2015 06 UPD
NEWS YOU CAN USE 2015 06 UPD

... • Eluxadoline is dosed 75 mg or 100 mg twice daily with food. • Rifaximin is dosed 550 mg three times daily for 14 days. Patients can be retreated twice with same regimen. 05/25/2015 FDA News and Events ...
5woo catjan2006 print
5woo catjan2006 print

... • CA Dept of Justice Bureau of Narcotic Enforcement • Drug Enforcement Administration ...
project description - Standard drugs and drug standards
project description - Standard drugs and drug standards

... Recently the ESF Networking Program “Drug Standards, Standard Drugs” has hosted a number of discussions and conferences on the standardization of pharmaceuticals and standardization processes in general. My research project tries to invert the perspective on substances asking whether the standardiza ...
Introduction - Indian Pharmacopoeia Commission
Introduction - Indian Pharmacopoeia Commission

... Essential Medicines, other medicines frequently prescribed by clinicians and medicines for use in India's public health programs and National Health Missions. The scope of this edition has been expanded substantially by incorporating several important Chapters. Some of these are: Inclusion of 33 cha ...
Orphan Medicinal Products 2000 - 2004
Orphan Medicinal Products 2000 - 2004

... What is an Orphan Medicinal Product Orphan Medicinal Products  for rare diseases  development costs > expected return on investment  life-threatening or very serious Lack of sponsors developing orphan medicinal products ...
What Rx is he taking?
What Rx is he taking?

... paradigm typically consists of… • 1st line Rx – used most - BEST CASE? • 2nd line Rx – used when one or more first line drugs have unacceptable side effects/don’t work; sometimes used in combination with first line • 3rd line Rx – more potent, more side effects; used when 1st and 2nd line both fail, ...
Module 22 Notes
Module 22 Notes

... Drugs that ________ that activity of the central nervous system without most of the ____ _____ associated with ...
Drugs in Perspective
Drugs in Perspective

... was popular prior to the rise of the Incan Empire as early as 3000 B.C.. -When the Spaniards conquered the Incas they realized the importance of the coca leaves to the natives ...
Polypharmacy: A Look into Over Medicating
Polypharmacy: A Look into Over Medicating

... keep an accurate record of all medications, including over-thecounter medication and herbs. Get into the habit of identifying all drugs by generic name and drug class. Make certain the drug being prescribed has a clinical indication. Know the side effect profile of the drugs being prescribed. Unders ...
Module 55: The Biomedical Therapies, Summary Notes
Module 55: The Biomedical Therapies, Summary Notes

... Prozac, Zoloft and Paxil are the most widely prescribed antidepressants and act as selective serotonin-reuptake-inhibitor (SSRI) drugs. There are also tricyclicantidepressant drugs that are no longer as popular as the SSRIs. you should know both types for this course. Studies have shown that there c ...
6.2 notes
6.2 notes

... – Drug is needed to continue emotional or psychological well-being – Powerful factor in continued drug use – Any drug can become a focus of psychological dependence – No physical withdrawal ...
Pharmacogenetics - UCSD Cognitive Science
Pharmacogenetics - UCSD Cognitive Science

... • Controversy about whether this should be available to anyone or only doctors and about its accuracy • https://www.navigenics.com/member ...
Tina said you all learned ALOT last week
Tina said you all learned ALOT last week

... How does this make you feel about the clinical studies that have been done with little attention to race/ethnicity? ...
< 1 ... 155 156 157 158 159 160 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report